AI assistant
GALECTIN THERAPEUTICS INC — Director's Dealing 2025
Nov 5, 2025
33422_dirs_2025-11-05_c41069c6-3e1d-48ae-b796-3ee92bb2e169.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2025-11-03
Reporting Person: CALLICUTT JACK W (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | Common Stock | M | 1300 | $1.98 | Acquired | 8914 | Direct |
| 2025-11-03 | Common Stock | S | 1300 | $6.01 | Disposed | 7614 | Direct |
| 2025-11-03 | Common Stock | M | 1260 | $1.11 | Acquired | 8874 | Direct |
| 2025-11-03 | Common Stock | S | 1260 | $6.01 | Disposed | 7614 | Direct |
| 2025-11-03 | Common Stock | M | 1250 | $1.72 | Acquired | 8864 | Direct |
| 2025-11-03 | Commno stock | S | 1250 | $6.01 | Disposed | 7614 | Direct |
| 2025-11-04 | Common stock | M | 8914 | $1.98 | Acquired | 16528 | Direct |
| 2025-11-04 | Common stock | S | 8914 | $6.07 | Disposed | 7614 | Direct |
| 2025-11-04 | Common stock | M | 8974 | $1.11 | Acquired | 16588 | Direct |
| 2025-11-04 | Common stock | S | 8974 | $6.07 | Disposed | 7614 | Direct |
| 2025-11-04 | Common stock | M | 10741 | $1.72 | Acquired | 18355 | Direct |
| 2025-11-04 | Common stock | S | 10741 | $6.07 | Disposed | 7614 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-03 | Stock option (right to buy) | $1.98 | M | 1300 | Disposed | 2032-01-24 | Common Stock (1300) | Direct |
| 2025-11-03 | Stock option (right to buy) | $1.11 | M | 1260 | Disposed | 2033-01-26 | Common Stock (1260) | Direct |
| 2025-11-03 | Stock option (right to buy) | $1.72 | M | 1250 | Disposed | 2034-01-22 | Comm stock (1250) | Direct |
| 2025-11-04 | Stock option (right to buy) | $1.98 | M | 8914 | Disposed | 2032-01-24 | Common stock (8914) | Direct |
| 2025-11-04 | Stock option (right to buy) | $1.11 | M | 8974 | Disposed | 2034-01-26 | Common stock (8974) | Direct |
| 2025-11-04 | Stock option (right to buy) | $1.72 | M | 10741 | Disposed | 2034-01-22 | Common stock (10741) | Direct |
Footnotes
F1: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.
F2: The shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023.
F4: The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024.
F5: The options vested as follows: 25% on each of June 30, 2024, December 31, 2024, and June 30, 2025, with 25% scheduled to vest on December 31, 2025.
F6: The shares were sold in multiple transactions at prices ranging from $6.00 to $6.25. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.